Cold News and Research

RSS

Research roundup: Colonscopy in the countryside; retiree health benefits; what should hip surgery cost?

Rural residents who commonly seek treatment for advanced stages of colorectal cancer have been thought to lack access to cancer screening and adjuvant therapy. ... Several theories have been postulated to explain these findings, some of which include low socioeconomic status, lower educational attainment, lack of insurance coverage, underinsurance, and travel distance to health care facilities.

21 Apr 2014

Allergist says people allergic to multiple trees may have tough allergy this spring

The polar vortex may be on its way out, but it's certainly leaving its footprints behind. As spring rolls in, people allergic to multiple trees may have a tough allergy season - a consequence of the cold winter, says Mark Dykewicz, M.D., professor of allergy and immunology at Saint Louis University.

17 Apr 2014

Scientists discover protein potentially good target for influenza A virus

Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus.

11 Apr 2014

EU-funded project aims to find solution to combat hepatitis C epidemic in Egypt

New ways to differentiate between chronic and self-clearing infections may help towards effective patient management and reduce drug costs. But there are major challenges in implementation.

11 Apr 2014

Experts connect sleep deprivation to elevated risk of developing diabetes

Excessive noise is a common cause for a loss of sleep. Now, experts connect sleep deprivation to an elevated risk of developing diabetes.

10 Apr 2014

Novel prediction model improves patient outcomes after paracetamol-induced acute liver failure

In the UK paracetamol toxicity is the most common cause of ALF and has a high mortality rate. It is estimated that 150 to 200 deaths and 15 to 20 LTs occur as a result of poisoning each year in England and Wales.

10 Apr 2014

New book is an essential resource for academic scientists working in biomedicine

Cold Spring Harbor Laboratory Press is pleased to announce the publication of Connecting with Companies: A Guide to Consulting Agreements for Biomedical Scientists by Edward Klees, J.D. and H. Robert Horvitz, Ph.D. The book is an essential resource for academic scientists and physicians considering consulting work in biomedicine.

10 Apr 2014

Food allergies are closely linked to spring allergies, says allergist

The Midwest's high tree pollen count is primarily birch and oak, bad news for carrot, celery and almond lovers. "It's healthy if certain foods make your mouth water but it is unhealthy if foods make your nose run or your gums and throat itch," says Joseph Leija, MD, allergist who performs the Gottlieb Allergy Count, the official allergy count for the Midwest.

8 Apr 2014

Research: Chronic sleep deprivation linked to heart failure

Poor sleep doubles hospitalisations in heart failure, according to new research in nearly 500 patients presented today at EuroHeartCare 2014.

7 Apr 2014

Nurses guide patients into trance during procedure

Visualising a safe place reduces operative pain, according to research presented today at EuroHeartCare 2014. Nurses guided patients into a trance and found it helped patients cope with pain and anxiety during ablation of atrial fibrillation (AF).

7 Apr 2014

Nearly six in ten don't get enough sleep, says online survey

New online research, conducted to coincide with the publication of Professor Richard Wiseman's latest book Night School, suggests that nearly six in ten (59%) of adults in Britain - over 28 million people - are now sleep deprived and getting seven hours or less sleep each night.

4 Apr 2014

Eating watermelon reduces blood pressure in overweight individuals

Be sure to pick up a watermelon - or two - at your neighborhood farmers' market. It could save your life.

4 Apr 2014

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma SA, an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces an exclusive supply and license agreement for Sitavig® (Acyclovir Lauriad®) with Daewoong Pharmaceutical Co., Ltd. for commercialization rights in South Korea.

2 Apr 2014

Nearly 4 million infants die from vaccine-preventable diseases worldwide each year

Nearly 4 million children under 5 die from vaccine-preventable diseases worldwide each year, and two University of Michigan doctoral ecology students are working to change that.

2 Apr 2014

Early life chronic stress may cause anxiety in adulthood, says study

In recent years, behavioral neuroscientists have debated the meaning and significance of a plethora of independently conducted experiments seeking to establish the impact of chronic, early-life stress upon behavior - both at the time that stress is experienced, and upon the same individuals later in life, during adulthood.

28 Mar 2014

Novel storage device transports vaccines to remote parts of the world

Getting life-saving vaccines to the most remote parts of the world is no easy feat. Biopharmaceuticals are highly sensitive to heat and cold and can perish if their temperature shifts a few degrees.

27 Mar 2014

A fast, non-invasive method to genotype late-onset Alzheimer's disease

The apolipoprotein E gene ε4 allele is considered a negative factor for neural regeneration in late-onset Alzheimer's disease cases.

27 Mar 2014

ASU scientist selected as 2014 recipient of Lifetime Achievement Award

Roy Curtiss III, a scientist at the Biodesign Institute at Arizona State University, has been selected as the 2014 recipient of the Lifetime Achievement Award from the American Society for Microbiology.

26 Mar 2014

Researchers develop mathematical model that provides insights about molecular mechanisms behind virus assembly

Mathematicians at the University of York have joined forces with experimentalists at the University of Leeds to take an important step in discovering how viruses make new copies of themselves during an infection.

25 Mar 2014

Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Today Biogen Idec announced that Health Canada has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B.

21 Mar 2014